共 50 条
[37]
Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
[J].
Advances in Therapy,
2021, 38
:3154-3165